# FDA 483 - Biocon Biologics Limited - July 26, 2024

Source: https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/05a654d1-f83f-49b1-80a9-56f70dca615f

> FDA 483 for Biocon Biologics Limited on July 26, 2024. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Biocon Biologics Limited
- Inspection Date: 2024-07-26
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2019-02-15](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/3858f9b9-9837-4adb-9001-eeb4c7a62761)
- [483 - 2017-04-07](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/9003f4e1-97b6-4bc9-89a4-c3d018f10822)
- [483 - 2018-05-01](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/6fa7e974-b5c4-450b-bb8f-8eb76ae4b514)
- [483 - 2017-06-03](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/d469f0a6-221d-4b96-a912-d98125df7f1b)
- [483 - 2022-08-19](https://www.globalkeysolutions.net/records/483/biocon-biologics-limited/152eb2db-adeb-44c2-883a-bdac69a6cc99)

## Related Officers

- [Teresa I. Navas](https://www.globalkeysolutions.net/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa)
- [Research Specialist II](https://www.globalkeysolutions.net/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Xiaoshi Wang](https://www.globalkeysolutions.net/people/xiaoshi-wang/8249ff14-dec6-4ffd-9893-bdf8ba6af7ce)
- [Richard Ledwidge](https://www.globalkeysolutions.net/people/richard-ledwidge/aaf4f089-8f7a-4d1f-b2e1-5f2e476a22a9)

Company: https://www.globalkeysolutions.net/companies/biocon-biologics-limited/7eb84509-8dc4-4765-9a0e-d2f65781328d

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
